A carregar...
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts
OBJECTIVES—Recent phase III clinical trials of immunomodulatory therapies in relapsing-remitting multiple sclerosis have shown significant benefits of active treatment on relapse related end points, but effects on disability outcomes have been inconsistent. These apparent discrepancies could be due...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1736854/ https://ncbi.nlm.nih.gov/pubmed/10727480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.4.450 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|